Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-07 | Amended | $25,686,104 | $0 | Equity Only | 06b | SEC link |
| 2025-01-06 | New | $25,686,104 | $25,686,104 | Equity Only | 06b | SEC link |
| 2024-02-01 | New | $1,539,999 | $1,539,999 | Equity Only | 06b | SEC link |
| 2022-02-01 | Amended | $9,500,000 | $4,850,000 | Equity Only | 06b | SEC link |
| 2021-11-03 | New | $4,650,000 | $4,650,000 | Equity Only | 06b | SEC link |
| 2018-10-16 | New | $350,000 | $350,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Alexander J. Aranyosi | Executive |
| Roozbeh Ghaffari | Director, Executive |
| Laura Lang | Director |
| Stephen Lee | Executive |
| Weihua Li | Executive |
| Jeff Model | Executive |
| Jeffrey Model | Executive |
| Kimberly Querrey | Director |
| John Rogers | Director |
| James Ryan | Executive |
| John Wright | Executive |